NICE Negative on Tocilizumab “drastically limits” Treatment Options for Patients with Severe Rheumatoid Arthritis

News   Mar 15, 2010

 
NICE Negative on Tocilizumab “drastically limits” Treatment Options for Patients with Severe Rheumatoid Arthritis
 
 
 

RELATED ARTICLES

Anti-Inflammatory Pill Could Make Vaccines More Effective for the Elderly

News

By identifying why skin immunity declines in old age, a UCL-led research team has found that an anti-inflammatory pill could help make vaccines more effective for elderly people.

READ MORE

Patent Plausability Case Sees BIA Intervention

News

The UK Bioindustry Association (BIA) will intervene in a court case which could have huge ramifications for UK bioscience.

READ MORE

PPD and Quotient Sciences Form Innovative Partnership to Accelerate Pediatric Drug Development

News

Will shorten timelines, reduce costs and simplify contracting process in pediatric programs.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE